Search Results

Kura Oncology Presents Updated Clinical Data from KOMET-001 Trial of Menin Inhibitor Ziftomenib at ASH Annual Meeting

SAN DIEGO, Dec. , - Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for th…

MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

Planegg/Munich, Germany, December , - MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced results from analyses of the ongoing MANIFEST study, an P…

Family Support Groups – Utah & Wyoming

Local LLS Support GroupsMyeloproliferative Neoplasms Support Group — THIS GROUP MEETS VIRTUALLYLogin information will be provided to participants aft…

Support Resources

Loxley

In early September of , my son started to complain of back pain. I took him to the pediatrician, where he was assessed and a multiview was ordered. I…

COVID Updates: Where We Are and Where We Go From Here

We invite you to learn more about: How has evolved Safety tips for immunocompromised patients Current treatment advances Living with COVID thr…

Explaining Cancer to Students: A Classroom Presentation

This classroom presentation demonstrates how to talk to children about their classmate with cancer, including understanding key words, answering commo…

A Panel Discussion on Transitioning Your Student Back to School: Practical Tips and Advice

Watch this informative panel discussion of school personnel for practical tips on supporting a student attending school during or after cancer treatme…

Shameel

Telling a child that they have cancer and explaining what that means is one of the most difficult conversations you can have with your child.Shameel w…

Sarah

My daughter Sarah was a fun, smart, and scrappy kid. She was a great student, was involved in Student Council, was President of her class, played in t…

NCI Genetic Epidemiology Branch- Familial Blood and Lymph Node Cancers

To study families with multiple cases of lymphoproliferative disorders. The National Cancer Institute (NCI) of the National Institutes of Health…

FDA Approves the First-in-Class Bispecific Antibody for Treatment of Follicular Lymphoma

“This new treatment has the potential to help patients with this cancer achieve remission,” says LLS Chief Scientific Officer Dr. Lee Greenberger.

Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds Over PLN 250 Million ($57M USD)

Krakow, Poland – December , – Ryvu Therapeutics [WSE:RVU], a drug discovery and development company focusing on novel small molecule therapies that …

Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009

WALTHAM, Mass., January , – Immunitas Therapeutics (“Immunitas”), a clinical stage precision immunotherapy company committed to discovering and devel…

Mosunetuzumab-axgb

Insured Cancer Patients Continue to Face Barriers To Medically Necessary Treatment, New Report Warns

The new report published by The Leukemia & Lymphoma Society and Manatt Health offers concrete policy solutions.

News Release

Asistencia Financiera Dental para Veteranos

¿TIENES DEUDA MEDICA? ES POSIBLE QUE Blood Cancer United PUEDA AYUDARHaga clic aquí para obtener más información Esta página contiene información sobr…

Education Resources

What’s Next in Blood Cancer: Looking Ahead to 2023

The most important blood cancer scientific meeting, the American Society of Hematology (ASH), is held every December. This meeting, followed closely b…

Sally

In January , my new life journey was about to begin. After doctor visits, bloodwork, testing, and finally complete shock, the diagnosis of cancer was …

BioInvent Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program and Receives $3 Million Strategic Equity Investment

Lund, Sweden – January , – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and developm…